The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.12016-12017
Hauptverfasser:	Vassilakopoulos, Theodoros P., Arapaki, Maria Panagiota, Diamantopoulos, Panagiotis T, Angelopoulou, Maria K., Nadali, Gianpaolo, Tsourouflis, Gerasimos, Moschogiannis, Maria, Dimopoulou, Maria, Siakantaris, Marina, Yiakoumis, Xanthi, Kontopidou, Flora, Kalpadakis, Christina H., Gainaru, Gabriela, Asimakopoulos, John V., Dimou, Maria, Sachanas, Sotirios, Kyrtsonis, Marie-Christine, Tsaftaridis, Panayiotis, Plata, Eleni, Variami, Eleni, Viniou, Nora-Athina, Pizzolo, Giovanni, Sarris, Andreas H., Konstantopoulos, Kostas, Panayiotidis, Panayiotis, Pangalis, Gerassimos
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!